Financials
- Market Capitalization 1.59 B
- Employee 140
- Founded 2011
- CEO N/A
- Website www.absci.com
- Headquarter Washington, United States
- FIGI BBG011N54CJ8
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-3.66
ratio cours/chiffre d'affaires
223.3
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2145 | INVA Innoviva, Inc. - Common Stock | 21.90 USD | +0.74% | -1.66% | -4.66% | +22.90% | 1.62 B USD | ||
| 2146 | VIR Vir Biotechnology, Inc. - Common Stock | 9.47 USD | -0.21% | -8.41% | +9.86% | +58.36% | 1.60 B USD | ||
| 2159 | SEPN Septerna, Inc. - Common Stock | 33.98 USD | -1.62% | -5.66% | -5.43% | +54.38% | 1.53 B USD | ||
| 2172 | AVBP ArriVent BioPharma, Inc. - Common Stock | 32.83 USD | +0.89% | -4.51% | +7.99% | +50.73% | 1.53 B USD |